免疫复合体的体内清除:对人类药物/抗药物抗体复合体清除动态的洞察
Eugenia Opolka-Hoffmann1, Stephen Fowler2, Thomas Bach3
1Pharmaceutical Sciences, Roche Pharma Research and Early Development, Roche Innovation Center Munich, Roche Diagnostics GmbH, Nonnenwald 2, DE-82377, Penzberg, Germany. Eugenia.opolka-hoffmann@roche.com.
抗药抗体 (ADA) 与生物治疗药物形成免疫复合体 (IC),影响药物的有效性和安全性. 这项研究发现,较大的免疫综合体在患者中清除的速度更快,突出了先进的药理动力学测试的必要性.
科学领域:
- 生物制药的免疫性 生物制药的免疫性
- 临床免疫学 临床免疫学
- 药理动力学 药理动力学
背景情况:
- 单克隆抗体 (mAbs) 和生物治疗药物的免疫性是一个临床挑战.
- 抗药抗体 (ADA) 可以中和药物,加速清除,降低疗效,并通过免疫复合体 (IC) 引起过敏.
- 目前的测定提供有限的洞察力的人类IC动态.
研究的目的:
- 在接受新型T细胞参与剂TYRP1-TCB的患者中研究免疫复合体 (IC) 的形成和清除.
- 评估ADA形成对临床环境中的药物药理动力学和IC动态的影响.
主要方法:
- 来自终止的TYRP1-TCB的第一阶段临床试验的患者样本分析.
- 使用尺寸排除色谱 (SEC) 和酶相关免疫吸收试验 (ELISA) 来评估ICs.
- 评估药物和ADA水平,以了解它们与IC形成和清除的关系.
主要成果:
- 六名患者发展了ADAs,导致IC形成.
- 检测到各种大小的IC,较大的复杂物表现出更快的清除率.
- 证明,当ADA存在时,总药物PK测定可能会高估暴露.
结论:
- 了解ADA和IC动态对于安全有效的生物治疗使用至关重要.
- 当前的PK测定可能不会准确地反映在免疫反应存在时的药物暴露.
- 需要进一步研究先进的PK测定,以鉴定IC的特征.
更多相关视频
08:53In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
Published on: September 16, 2019
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
相关概念视频
Drug Elimination: The Concept of Clearance
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination,...
Drug Clearance: Overview
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination, including...
Kinetics of Drug Elimination
Drug clearance depends on the rate of drug elimination and its plasma concentration. Another important parameter is the half-life of a drug, which is the time required for its concentration to decrease by half. In most cases, drug clearance follows first-order...
Clearance Models: Compartment Models
Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
Clearance Models: Noncompartmental Models
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
